Cargando…
Antiasthmatic Inhaled Medications as Favoring Factors for Increased Concentration of Streptococcus Mutans
INTRODUCTION: The negative impact of inhaled antiasthmatic drugs (IAD) on oral health is reflected primarily in the increased incidence of caries in asthmatic children compared to healthy children. It is believed that one of the causes of the increased incidence of caries in asthmatic children is fr...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AVICENA, d.o.o., Sarajevo
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610621/ https://www.ncbi.nlm.nih.gov/pubmed/26543413 http://dx.doi.org/10.5455/msm.2015.27.237-240 |
_version_ | 1782395978430545920 |
---|---|
author | Brigic, Amela Kobaslija, Sedin Zukanovic, Amila |
author_facet | Brigic, Amela Kobaslija, Sedin Zukanovic, Amila |
author_sort | Brigic, Amela |
collection | PubMed |
description | INTRODUCTION: The negative impact of inhaled antiasthmatic drugs (IAD) on oral health is reflected primarily in the increased incidence of caries in asthmatic children compared to healthy children. It is believed that one of the causes of the increased incidence of caries in asthmatic children is from bronchodilator effect in reduced secretion of saliva. Decreased salivation favors bacterial colonization and studies have shown that the concentration of Streptococcus mutans, a bacterium that has the primary role in the development of caries, is higher in asthmatic than in healthy children. MATERIAL AND METHODS: The study sample consisted of 200 patients, age from 7-14 years, divided into two groups: control group (n1 = 100) consisted of healthy children and the experimental group consisted of children suffering from asthma (n2 = 100). In both groups of respondents are identified the DMFT values, the concentration of Streptococcus mutans, the amount of stimulated saliva and plaque index value. RESULTS: It was found that there are significant differences in the values of plaque index, salivary index and streptococcus mutans between the control and experimental groups (p> 0.05 for each of the examined variables). Those in the control group had significantly higher DMFT index than subjects in the experimental group (p = 0.004). CONCLUSION: IAD does not cause reduced saliva production and thus do not represent a factor favoring increased concentration of Streptococcus mutans. |
format | Online Article Text |
id | pubmed-4610621 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | AVICENA, d.o.o., Sarajevo |
record_format | MEDLINE/PubMed |
spelling | pubmed-46106212015-11-05 Antiasthmatic Inhaled Medications as Favoring Factors for Increased Concentration of Streptococcus Mutans Brigic, Amela Kobaslija, Sedin Zukanovic, Amila Mater Sociomed Original Paper INTRODUCTION: The negative impact of inhaled antiasthmatic drugs (IAD) on oral health is reflected primarily in the increased incidence of caries in asthmatic children compared to healthy children. It is believed that one of the causes of the increased incidence of caries in asthmatic children is from bronchodilator effect in reduced secretion of saliva. Decreased salivation favors bacterial colonization and studies have shown that the concentration of Streptococcus mutans, a bacterium that has the primary role in the development of caries, is higher in asthmatic than in healthy children. MATERIAL AND METHODS: The study sample consisted of 200 patients, age from 7-14 years, divided into two groups: control group (n1 = 100) consisted of healthy children and the experimental group consisted of children suffering from asthma (n2 = 100). In both groups of respondents are identified the DMFT values, the concentration of Streptococcus mutans, the amount of stimulated saliva and plaque index value. RESULTS: It was found that there are significant differences in the values of plaque index, salivary index and streptococcus mutans between the control and experimental groups (p> 0.05 for each of the examined variables). Those in the control group had significantly higher DMFT index than subjects in the experimental group (p = 0.004). CONCLUSION: IAD does not cause reduced saliva production and thus do not represent a factor favoring increased concentration of Streptococcus mutans. AVICENA, d.o.o., Sarajevo 2015-08 /pmc/articles/PMC4610621/ /pubmed/26543413 http://dx.doi.org/10.5455/msm.2015.27.237-240 Text en Copyright: © Amela Brigic, Sedin Kobaslija, Amila Zukanovic http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Paper Brigic, Amela Kobaslija, Sedin Zukanovic, Amila Antiasthmatic Inhaled Medications as Favoring Factors for Increased Concentration of Streptococcus Mutans |
title | Antiasthmatic Inhaled Medications as Favoring Factors for Increased Concentration of Streptococcus Mutans |
title_full | Antiasthmatic Inhaled Medications as Favoring Factors for Increased Concentration of Streptococcus Mutans |
title_fullStr | Antiasthmatic Inhaled Medications as Favoring Factors for Increased Concentration of Streptococcus Mutans |
title_full_unstemmed | Antiasthmatic Inhaled Medications as Favoring Factors for Increased Concentration of Streptococcus Mutans |
title_short | Antiasthmatic Inhaled Medications as Favoring Factors for Increased Concentration of Streptococcus Mutans |
title_sort | antiasthmatic inhaled medications as favoring factors for increased concentration of streptococcus mutans |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610621/ https://www.ncbi.nlm.nih.gov/pubmed/26543413 http://dx.doi.org/10.5455/msm.2015.27.237-240 |
work_keys_str_mv | AT brigicamela antiasthmaticinhaledmedicationsasfavoringfactorsforincreasedconcentrationofstreptococcusmutans AT kobaslijasedin antiasthmaticinhaledmedicationsasfavoringfactorsforincreasedconcentrationofstreptococcusmutans AT zukanovicamila antiasthmaticinhaledmedicationsasfavoringfactorsforincreasedconcentrationofstreptococcusmutans |